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Zataria multiflora is a medicinal plant that has been interested in antimutagenicity effect because of its high antioxidant activity and richness of flavonoids. Antimutagenicity effect of total extract of the plant has been reported previously. 
Aerial parts of Z. multiflora were extracted by petroleum ether, chloroform and 80% methanol by liquid‑liquid extraction 
method consequently. The fractions were concentrated in vacuum and dried at 40°C in oven. The genotype of two standard 
strains of Salmonella typhimurium (TA98, TA100) was confirmed by the evaluation of two important factors of histidine 
requirement and the presence of R factor. The minimum inhibition concentration (MIC) of the fractions against these two 
strains was determined by agar dilution method. From each fraction, various concentrations less than MIC were studied 
for anti‑mutagenic test. The sample along with bacterial strain and mutagen agent were incubated at 37°C for 48 h. The 
number of revertant colonies was counted and compared with control plates. Our results showed that all fractions especially 
petroleum ether and chloroform ones maintain the number of colonies in the standard range in control plates and prevent 
from the growth of many strains of bacteria and increase of revertant colonies enhancement in a concentration‑dependent 
manner. This effect was prominent against TA100 starin. Methanolic fraction exhibited anti‑mutagen activity just in the 
highest used concentration in the presence of TA98.
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INTRODUCTION
The available anticancer drugs have restricted 
uses and different side effects, so the need for 
drugs with different mechanisms and fewer side 
effects, is felt. Research for newer and especially 
herbal drugs has always attracted the attention of 
researchers.[1] The Ames test is one of the initial 
tests used in preliminary screening of compounds 
with antimutagenicity effect because of its simplicity, 
quickness, and convenience.[2] This test uses several 
strains of Salmonella typhimurium that carry mutations 
in genes involved in histidine synthesis (histidine 
operon), so they cannot synthesis some enzymes 
needed for histidine biosynthesis. A reversion back 
of these mutants to a prototrophic state, influenced 
by different chemical or environmental factors, can be 
studied in order to achieve mutagen and anti‑mutagen 
compounds.[3] Several studies have pointed out that 
many mutagenic and carcinogenic damages are caused 
by free radicals.[4] So it is expected compounds with 
antioxidant effect would be a good candidate for 
finding new antimutagenic agents.
Zataria multiflora Boiss known as Avishane‑Shirazi 
belongs to Lamiaceae family that has antiviral, 
antibacterial and antioxidant effects.[5] Our recently 
research has shown that the methanolic extract of 
Z. multiflora has antioxidant and antimutagenicity 
effects,[6] and because of a close relationship between 
antioxidant and antimutagenicity effects, the aim of 
this study was to evaluate the antimutagenicity effect 
of major fractions of methanolic extract of Z. multiflora 
by Ames method.
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